Bristol Myers Squibb has successfully concluded its acquisition of cancer drugmaker Mirati Therapeutics, impacting its 2024 adjusted earnings by approximately $0.35 per share, as part of the company's efforts to diversify its oncology portfolio.
ShaMaran Petroleum is set to increase its indirect working interest in the Atrush Block in Kurdistan from 27.6% to 50% through a two-step transaction, involving the acquisition of TAQA's 47.4% interest and the sale of a 25% interest and operatorship to HKN Energy IV, aligning with ShaMaran's consolidation strategy in the region.
Zee Entertainment seeks a second deadline extension with Sony for their merger as the companies grapple with unresolved issues, primarily revolving around the future role of Zee CEO Punit Goenka in the merged entity, with the deadline just hours away.
The article explores SiteOne Landscape Supply's valuation and introduces the significance of multiples in finance for comparing companies within the same industry, distinguishing between Equity Multiples and Enterprise Multiples.
